SWOT Analysis for Tempest Therapeutics Inc - Weakness

Add SWOT widget to your site/app

Significant (over 30%) distance from 52 week high

Relative Outperformance versus Industry over 1 Year

PEG lower than Industry PEG

Companies with reducing Debt

Increasing profits every quarter for the past 3 quarters

Stock with Low PE (PE < = 10)

Highest Recovery from 52 Week Low

Negative Breakdown First Support (LTP < S1)

Stocks with Quarter Change % less than Industry

Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score

Lowest Momentum Scores (Technical Scores)

Oversold by Money Flow Index (MFI)

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Inefficient use of assets to generate profits - ROA declining in the last 2 years

Highest fall from 52 Week High

Top Losers

Negative Breakdown First Support (LTP < S1)

Low Piotroski Score : Companies with weak financials

Declining Net Cash Flow : Companies not able to generate net cash

Weak performer : Stock lost more than 20% in 1 month

Weak Momentum: Price below Short, Medium and Long Term Averages

Top Losers

Stocks Underperforming their Industry Price Change in the Quarter

Companies with Upcoming Results

Mutual Funds Increased Shareholding in Past Month

Mutual Funds Increased Shareholding over the Past Two Months

MFs increased their shareholding last quarter

Mf buying for 2 months

Red Flags: Weakening Technicals and Share Price Decline

Institutions decreased their shareholding last quarter